Statistics for Phase I, Pharmacogenomic, Drug Interaction Study of Sorafenib and Bevacizumab in Combination with Paclitaxel in Patients with Advanced Refractory Solid Tumors
Total visits
| views | |
|---|---|
| Phase I, Pharmacogenomic, Drug Interaction Study of Sorafenib and Bevacizumab in Combination with Paclitaxel in Patients with Advanced Refractory Solid Tumors | 69 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:77c6929d-6309-4aef-87f3-154c6712c454 | 54 |
| Chiorean2020Phase1-NIHAAM.pdf | 48 |
| java.util.UUID:08a2c1f9-8fc8-4dad-9fe3-e0046444f770 | 33 |
| java.util.UUID:24dbfb87-a568-47aa-94e1-9f7a1e8a53fd | 7 |
Top country views
| views | |
|---|---|
| United States | 58 |
| Romania | 2 |
| Denmark | 1 |
| United Kingdom | 1 |
| Malaysia | 1 |
| Sweden | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 39 |
| Houston | 7 |
| Fairfield | 3 |
| Cambridge | 2 |
| Indianapolis | 2 |
| Aarhus | 1 |
| Ann Arbor | 1 |
| Galati | 1 |
| Kuala Lumpur | 1 |
| Malmö | 1 |
| Mount Laurel | 1 |
| Tarnaveni | 1 |
| Warrington | 1 |
| Washington | 1 |
| White Plains | 1 |